Therefore, further research on more types of cancer and the high levels of PGK1 in/out of cells is needed to determine whether PGK1 is an inhibitor or activator of tumours, and these studies will support the accurate use of PGK1 therapy in the treatment of cancer. The gene discussed is PGK1; the disease is cancer.